Unbiased, Mass Spectrometry-Based Proteomic Analysis
Discovery proteomics allows for a global view of the proteome, enabling the identification and relative quantification of thousands of proteins in your samples. Panome Bio’s discovery proteomics offerings enable researchers to explore cellular processes and disease mechanisms with unprecedented depth and insights.
Panome Bio has two species-agnostic discovery proteomics platforms which include a bio-fluid based offering built with the Seer Proteograph™ XT coupled with the Thermo Fisher Orbitrap Astral mass spectrometer as well as a separate, tissue-based untargeted mass spectrometry-based approach well suited for all sample types. With a more complete view of the proteome, the experts at Panome Bio can perform robust multi-omic analyses, profile unknown peptide variants, and achieve insights that were previously not possible.